‹ INBX latest research

INBX (Inhibrx Biosciences, Inc.): every AI call and what happened next

TradeFlare's AI research teams analysed INBX on 7 market nights between September 9, 2026 and October 1, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.

7 calls 1 BUY · 6 HOLD · 0 SELL
DateVerdictPriceTarget / stop5 days later20 days laterWhy (that night)
October 1, 2026 HOLD $100.08 $120.09 / $85.07 not yet not yet
The insider buying is a strong signal, but the neutral technicals and high risk necessitate a cautious approach with a longer time horizon to allow the fundamental story to play out.
September 28, 2026 HOLD $99.61 — / — not yet not yet
The current market conditions and the stock's technical setup do not warrant a buy at this time.
September 24, 2026 HOLD $100.33 — / — not yet not yet
The current market regime and the stock's technical and risk profile do not support a buy recommendation at this time.
September 22, 2026 HOLD $112.04 — / — not yet not yet
The current market conditions and the stock's technical setup do not warrant a buy at this time.
September 18, 2026 BUY $104.73 $120.44 / $89.02 not yet not yet
The insider buying and positive fundamental/sentiment signals suggest a medium-term upward trend.
September 11, 2026 HOLD $111.42 $133.70 / $94.71 not yet not yet
The insider buying is a strong signal, but the neutral technicals and high risk require a cautious approach with a longer time horizon to allow the setup to mature.
September 9, 2026 HOLD $114.34 — / — not yet not yet
The current market regime and the stock's neutral technicals necessitate a cautious approach, awaiting clearer signals.

Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.